Mindin/Spondin-2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-52031
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-RKNQYVSNGLRDFA corresponding to internal region according to NP_036577.1.
Epitope
C-RKNQYVSNGLRDFA
Specificity
Reported variants NP_036577.1 and NP_001121797.1 represent identical protein.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Mindin/Spondin-2 Antibody
Western Blot: Mindin/Spondin-2 Antibody [NBP1-52031]
Western Blot: Mindin/Spondin-2 Antibody [NBP1-52031] - NBP1-52031 (1ug/ml) staining of Human Prostate lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for Mindin/Spondin-2 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:16000
Western Blot
0.5 - 1.5 ug/ml
Application Notes
WB: Approx. 35 kDa band observed in human prostate lysates (calculated MW of 35.8 kDa band according to NP_036577.1).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: Mindin
Alternate Names
DIL1, RG-1, SPON2, Spondin 2
Entrez Gene IDs
10417 (Human)
Gene Symbol
SPON2
UniProt
Additional Mindin Products
Product Documents for Mindin/Spondin-2 Antibody
Product Specific Notices for Mindin/Spondin-2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...